Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Inge van der Sluis

Inge van der Sluis

Kinderoncoloog

Trial- en Datacentrum
Zwaan groep

Telefoon

E-mail I.M.vanderSluis@prinsesmaximacentrum.nl

Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL
- feb. 2024
- Inge M, van der Sluis, et al
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups
- sep. 2023
- Rob, Pieters, et al
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands
- jan. 2023
- Emily R., Schwartz, et al
- BMJ open
Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib
- jan. 2023
- Inge, van der Sluis, et al
- EJC Pediatric Oncology
Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)
- jan. 2023
- Aniek, Uittenboogaard, et al
- Cancer Medicine

Bekijk alle publicaties

Inge van der Sluis

Publicaties

Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands

Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib

Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)